Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current Assets:
Cash and cash equivalents	$ 23,677,111	$ 27,714,588
Accounts receivable	7,884,665	9,073,173
Inventories	6,852,386	5,326,962
Deferred costs	1,712,139	1,773,446
Prepaid expenses and other current assets	1,520,125	1,376,299
Total current assets	41,646,426	45,264,468
Equipment, molds, furniture and fixtures, net	17,607,938	17,867,412
Patent rights, net	1,924,619	2,044,608
Goodwill	1,095,355	1,095,355
Other assets	53,675	53,607
Total Assets	62,328,013	66,325,450
Current Liabilities:
Accounts payable	8,687,427	7,884,983
Accrued expenses and other liabilities	7,108,360	5,872,846
Deferred revenue	3,928,590	6,149,087
Total current liabilities	19,724,377	19,906,916
Deferred revenue – long term	1,200,000	1,200,000
Total liabilities	20,924,377	21,106,916
Stockholders’ Equity:
Preferred Stock: $0.01 par, authorized 3,000,000 shares, none outstanding
Common Stock: $0.01 par; 300,000,000 shares authorized; 155,447,871 and 155,167,677 issued and outstanding at March 31, 2017 and December 31, 2016, respectively	1,554,479	1,551,677
Additional paid-in capital	298,837,495	297,826,433
Accumulated deficit	(258,278,409)	(253,445,306)
Accumulated other comprehensive loss	(709,929)	(714,270)
Total Stockholders' Equity	41,403,636	45,218,534
Total Liabilities and Stockholders’ Equity	$ 62,328,013	$ 66,325,450